肾移植术后调节性T细胞的影响因素

斯迪克江·尼亚孜; 戎瑞明

doi:10.3969/j.issn.1674-7445.2016.05.014

肾移植术后调节性T细胞的影响因素

doi: 10.3969/j.issn.1674-7445.2016.05.014

200032 上海，复旦大学附属中山医院泌尿外科

详细信息

通讯作者:
戎瑞明，Email：rong.ruiming@zs-hospital.sh.cn

中图分类号: R617, R392.4
计量
- 文章访问数: 160
- HTML全文浏览量: 93
- PDF下载量: 8
- 被引次数: 0
出版历程
- 收稿日期: 2016-07-16
- 网络出版日期: 2021-01-19
- 刊出日期: 2016-09-15

摘要

摘要: 调节性T细胞(Treg)作为众所周知的具有负免疫调节功能的T细胞亚群，不仅可抑制急性缺血-再灌注损伤(IRI)中的先天性免疫，也可在肾移植术后调节免疫耐受中起着重要的作用。因此，正确认识和利用肾移植患者体内Treg分化、扩增、活性及作用机制等的影响因素，使其发挥负免疫调节功能至关重要。本文从内在生物因素、药物因素、移植肾相关因素等方面，对肾移植患者体内Treg的影响因素研究进展作一综述。
- 肾移植 /
- 调节性T细胞 /
- 缺血-再灌注损伤 /
- 排斥反应 /
- 免疫耐受

HTML全文

参考文献(33)

[1]	Kinsey GR, Sharma R, Huang L, et al. Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury[J]. J Am Soc Nephrol, 2009, 20(8):1744-1753. doi: 10.1681/ASN.2008111160
[2]	曹俊, 魏珂, 李庆姝, 等.调节性T淋巴细胞在小鼠肾缺血再灌注损伤中的作用[J].中华麻醉学杂志, 2013, 33(11):1397-1400. http://med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_zhmzxzz98201311030 Cao J, Wei K, Li QZ, et al. Role of regulatory T cells in renal ischemia-reperfusion injury in mice[J]. Chin J Anesthesiol, 2013, 33(11):1397-1400. http://med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_zhmzxzz98201311030
[3]	马林林, 任长虹, 曾现伟, 等.调节性T细胞在缺血再灌注损伤中的保护作用[J/CD].中华临床医师杂志(电子版), 2012, 6(23):7720-7722. http://www.cqvip.com/qk/88648x/201223/3000039811.html Ma LL, Ren CH, Zeng XW, et al. The protective role of regulatory T cells in renal ischemia-reperfusion injury[J/CD]. Chin J Clin(Electr Edit), 2012, 6(23):7720-7722. http://www.cqvip.com/qk/88648x/201223/3000039811.html
[4]	Siepert A, Ahrlich S, Vogt K, et al. Permanent CNI treatment for prevention of renal allograft rejection in sensitized hosts can be replaced by regulatory T cells[J]. Am J Transplant, 2012, 12(9): 2384-2394. doi: 10.1111/ajt.2012.12.issue-9
[5]	Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with Foxp3 and suppressive function of human CD4⁺Treg cells[J]. J Exp Med, 2006, 203(7):1701-1711. doi: 10.1084/jem.20060772
[6]	Kinsey GR, Huang L, Jaworska K, et al. Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection[J]. J Am Soc Nephrol, 2012, 23(9): 1528-1537. doi: 10.1681/ASN.2012010070
[7]	Dienz O, Rincon M. The effects of IL-6 on CD4 T cell responses[J]. Clin Immunol, 2009, 130(1): 27-33. doi: 10.1016/j.clim.2008.08.018
[8]	Wang H, Guan Q, Lan Z. Prolonged renal allograft survival by donor interleukin-6 deficiency: association with decreased alloantibodies and increased intragraft T regulatory cells[J]. Am J Physiol Renal Physiol, 2012, 302(2): F276-F283. doi: 10.1152/ajprenal.00258.2011
[9]	Matta BM, Turnquist HR. Expansion of regulatory T cells in vitro and in vivo by IL-33[J]. Methods Mol Biol, 2016, 1371: 29-41. doi: 10.1007/978-1-4939-3139-2
[10]	Akashi S, Sho M, Kashizuka H, et al. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection[J]. Transplantation, 2005, 80(3): 378-384. doi: 10.1097/01.tp.0000166338.99933.e1
[11]	Hoerning A, Köhler S, Jun C, et al. Peripherally circulating CD4⁺Foxp3⁺CXCR3⁺ T regulatory cells correlate with renal allograft function[J]. Scand J Immunol, 2012, 76(3): 320-328. doi: 10.1111/sji.2012.76.issue-3
[12]	Hanidziar D, Koulmanda M. Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance[J]. Curr Opin Organ Transplant, 2010, 15(4): 411-415. doi: 10.1097/MOT.0b013e32833b7929
[13]	Meng F, Chen S, Guo X, et al. Clinical significance of myeloid-derived suppressor cells in human renal transplantation with acute T cell-mediated rejection[J]. Inflammation, 2014, 37(5): 1799-1805. doi: 10.1007/s10753-014-9910-5
[14]	Luan Y, Mosheir E, Menon MC, et al. Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion[J]. Am J Transplant, 2013, 13(12): 3123-3131. doi: 10.1111/ajt.12461
[15]	Riella LV, Liu T, Yang J, et al. Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model[J]. Am J Transplant, 2012, 12(4):846-855. doi: 10.1111/j.1600-6143.2011.03929.x
[16]	La Manna G, Ghinatti G, Tazzari PL, et al. Neutrophil gelatinase-associated lipocalin increases HLA-G(+)/FoxP3(+) T-regulatory cell population in an in vitro model of PBMC[J]. PLoS One, 2014, 9(2):e89497. doi: 10.1371/journal.pone.0089497
[17]	袁渊, 曾甫清, 翟晓强, 等.性激素与CD4⁺CD25⁺调节性T细胞的相关性及在肾移植免疫耐受中的作用研究[J].临床泌尿外科杂志, 2010, 25(10):732-735. Yuan Y, Zeng PQ, Zhai XQ, et al. The relationship between sex hormones and regulation T Cells and its role in immune tolerance after renal transplantation[J]. J Clin Urol, 2010, 25(10):732-735.
[18]	Weinberg A, Enomoto L, Marcus R, et al. Effect of menstrual cycle variation in female sex hormones on cellular immunity and regulation[J]. J Reprod Immunol, 2011, 89(1):70-77. doi: 10.1016/j.jri.2010.11.009
[19]	Tang Q, Boden EK, Henriksen K, et al. Distinct roles of CTLA-4 and TGF-beta in CD4⁺CD25⁺ regulatory T cell function[J]. Eur J Immunol, 2004, 34(11):2996-3005. doi: 10.1002/(ISSN)1521-4141
[20]	Barnes MJ, Griseri T, Johnson AM, et al. CTLA-4 promotes Foxp3 induction and regulatory T cell accumulation in the intestinal lamina propria[J]. Mucosal Immunol, 2013, 6(2): 324-334. doi: 10.1038/mi.2012.75
[21]	Seissler N, Schmitt E, Hug F, et al. Methylprednisolone treatment increases the proportion of the highly suppressive HLA-DR⁺-Treg-cells in transplanted patients[J]. Transpl Immunol, 2012, 27(4): 157-161. doi: 10.1016/j.trim.2012.09.003
[22]	Gong N, Chen Z, Wang J, et al. Immunoregulatory effects of sirolimus vs. tacrolimus treatment in kidney allograft recipients[J]. Cell Immunol, 2015, 297(2):87-93. doi: 10.1016/j.cellimm.2015.07.002
[23]	Zhao T, Yang C, Qiu Y, et al. Comparison of regulatory T cells and FoxP3-positive T-cell subsets in the peripheral blood of renal transplant recipients with sirolimus versus cyclosporine: a preliminary study[J]. Transplant Proc, 2013, 45(1): 148-152. doi: 10.1016/j.transproceed.2012.06.067
[24]	Bocian K, Borysowski J, Wierzbicki P, et al. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4⁺CD25⁺Tregs[J]. Nephrol Dial Transplant, 2010, 25(3):710-717. doi: 10.1093/ndt/gfp586
[25]	Miroux C, Moralès O, Carpentier A, et al. Inhibitory effects of cyclosporine on human regulatory T cells in vitro[J]. Transplant Proc, 2009, 41(8):3371-3374. doi: 10.1016/j.transproceed.2009.08.043
[26]	Gandolfo MT, Jang HR, Bagnasco SM, et al. Mycophenolate mofetil modifies kidney tubular injury and Foxp3⁺ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion[J]. Transpl Immunol, 2010, 23(1/2): 45-52. http://www.ncbi.nlm.nih.gov/pubmed/20412855
[27]	Demirkiran A, Sewgobind VD, van der Weijde J, et al. Conversion from calcineurin inhibitor to mycophenolate mofetil-based immunosuppression changes the frequency and phenotype of CD4⁺Foxp3⁺ regulatory T cells[J]. Transplantation, 2009, 87(7):1062-1068. doi: 10.1097/TP.0b013e31819d2032
[28]	Krystufkova E, Sekerkova A, Striz I, et al. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy[J]. Nephrol Dial Transplant, 2012, 27(6):2576-2582. doi: 10.1093/ndt/gfr693
[29]	Zhao T, Yang C, Xue Y, et al. Impact of basiliximab on the proportion of regulatory T cells and their subsets early after renal transplantation: a preliminary report[J]. Transplant Proc, 2012, 44(1): 175-178. doi: 10.1016/j.transproceed.2011.11.026
[30]	Sewgobind VD, Kho MM, van der Laan LJ, et al. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients[J]. Nephrol Dial Transplant, 2009, 24(5):1635-1644. doi: 10.1093/ndt/gfn778
[31]	Zhang G, Chen J, Liu Y, et al. Triptolide-conditioned dendritic cells induce allospecific T-cell regulation and prolong renal graft survival[J]. J Invest Surg, 2013, 26(4):191-199. doi: 10.3109/08941939.2012.737408
[32]	Zhang G, Liu Y, Guo H, et al. Triptolide promotes generation of Foxp3⁺ T regulatory cells in rats[J]. J Ethnopharmacol, 2009, 125(1):41-46. doi: 10.1016/j.jep.2009.06.020
[33]	杜传福, 于立新, 付绍杰, 等.慢性移植肾肾病所致功能丧失移植肾切除与否对CD4⁺CD25⁺Treg细胞的影响[J].中华器官移植杂志, 2010, 31(3):177-180. Du CF, Yu LX, Fu SJ, et al. The change of CD4⁺CD25⁺regulatory T cells after the transplant nephropathy in human renal recipients with chronic allograft nephropathy[J]. Chin J Organ Transplant, 2010, 31(3):177-180.